Low rates of humoral response to BNT162b2 SARS-CoV-2 vaccination in patients with immune-mediated kidney diseases treated with rituximab

Clin Kidney J. 2021 Jun 11;14(9):2132-2133. doi: 10.1093/ckj/sfab102. eCollection 2021 Sep.

Authors

Nathalie Demoulin^{1

2}, Anaïs Scohy³, Valentine Gillion^{1

2}, Nathalie Godefroid⁴, Michel Jadoul^{1

2}, Johann Morelle^{1

2}

Affiliations

¹ Division of Nephrology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
² Institut de Recherche Expérimentale et Clinique, UCLouvain, Brussels, Belgium.
³ Department of Microbiology, Cliniques universitaires Saint-Luc, Brussels, Belgium.
⁴ Department of Pediatrics, Cliniques universitaires Saint-Luc, Brussels, Belgium.

No abstract available